他克莫司与卡泊三醇治疗斑块状银屑病的临床疗效研究
2017-09-25柴丽陈丽
柴丽 陈丽
[摘要] 目的 研究他克莫司和卡泊三醇在斑块状银屑病治疗中的临床效果。方法 该院方便选取从2016年3月—2017年3月间所收治的斑块状银屑病患者共86例作为研究的对象,分组方式为计算机表法,对照组(43例)、观察组(43例)。对照组予以卡泊三醇软膏,观察组予以他克莫司外用,对比2组在治疗4周之后的疗效与不良反应的产生。结果 观察组的治疗总有效率40例(93.02%)相较于对照组32例(74.42%)明显更高,予以统计学对比,组间差异有统计学意义(P<0.05);但是, 观察组在实施治疗的期间不良反应产生率是4.65%;对照组在实施治疗的期间不良反应发生率2.33%,观察组不良反应的产生率相较于对照组差异无统计学意义(P>0.05)。结论 针对斑块状银屑病的患者予以他克莫司外用治疗,相较于卡泊三醇软膏治疗具有更理想的疗效,可以将治疗的总有效率提升,可以视作有效性临床药物实现推广。
[关键词] 他克莫司;卡泊三醇;斑块状银屑病;疗效
[中图分类号] R758.63 [文献标识码] A [文章编号] 1674-0742(2017)07(c)-0112-03
[Abstract] Objective To research the clinical curative effect of tiotropium bromide and calcipotriol in treatment of plaque psoriasis. Methods 86 cases of patients with plaque psoriasis admitted and treated in our hospital from March 2016 to March 2017 were convenient selected and randomly divided into two groups with 43 cases in each, the control group adopted the calcipotriol cream, while the observation group adopted the external use of tacrolimus, and the curative effect and occurrence of adverse reactions after 4w were compared between the two groups. Results The total treatment effective rate in the observation group was obviously higher than that in the control group[40cases(93.02%) vs 32cases(74.42%)], and the difference between groups was obvious with statistical significance(P<0.05), however, the incidence rate of adverse reactions during the treatment in the observation group and in the control group was respectively 4.65% and 2.33%, and the difference was not obvious without statistical significance(P>0.05). Conclusion The curative effect of external use of tacrolimus in treatment of patients with plaque psoriasis is ideal than that of calcipotriol cream, which can effectively improve the total effective rate, and it can be widely promoted in clinic.
[Key words] Tacrolimus; Calcipotriol; Plaque psoriasis; Curative effect
银屑病属于一种极易复发且为慢性炎症性的皮肤疾病,比较多发且常见的是寻常性银屑病,截至到现今,病发的机制还没有明确,经研究已经显示,因为存有过大的精神压力、遗传、创伤等多种因素致使表皮细胞产生应激性反应,将T细胞活化诱导,进而令很多细胞因子进行释放且增加,以上都和该疾病的产生相关。现代临床对于银屑病的治疗虽然有很多的药物,但是却一直没有获取相对理想的疗效[1]。方便选取从2016年3月—2017年3月间该院所收治的斑块状银屑病患者共86例作为研究的对象,分为两组予以他克莫司和卡泊三醇,现报道如下。
1 资料与方法
1.1 一般资料
方便选取该院所收治的斑块状银屑病患者共86例作为研究的对象,分組方式为计算机表法,对照组(43例)、观察组(43例)。……
